These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 24702982)
1. The clinical impact of genetic susceptibility to prostate cancer. Bratt O Eur Urol; 2014 Sep; 66(3):500-1. PubMed ID: 24702982 [No Abstract] [Full Text] [Related]
2. Prostate cancer: What is the real IMPACT of BRCA1/BRCA2 mutation? Clyne M Nat Rev Urol; 2014 Mar; 11(3):124. PubMed ID: 24492431 [No Abstract] [Full Text] [Related]
4. Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. Mitra AV; Bancroft EK; Barbachano Y; Page EC; Foster CS; Jameson C; Mitchell G; Lindeman GJ; Stapleton A; Suthers G; Evans DG; Cruger D; Blanco I; Mercer C; Kirk J; Maehle L; Hodgson S; Walker L; Izatt L; Douglas F; Tucker K; Dorkins H; Clowes V; Male A; Donaldson A; Brewer C; Doherty R; Bulman B; Osther PJ; Salinas M; Eccles D; Axcrona K; Jobson I; Newcombe B; Cybulski C; Rubinstein WS; Buys S; Townshend S; Friedman E; Domchek S; Ramon Y Cajal T; Spigelman A; Teo SH; Nicolai N; Aaronson N; Ardern-Jones A; Bangma C; Dearnaley D; Eyfjord J; Falconer A; Grönberg H; Hamdy F; Johannsson O; Khoo V; Kote-Jarai Z; Lilja H; Lubinski J; Melia J; Moynihan C; Peock S; Rennert G; Schröder F; Sibley P; Suri M; Wilson P; Bignon YJ; Strom S; Tischkowitz M; Liljegren A; Ilencikova D; Abele A; Kyriacou K; van Asperen C; Kiemeney L; ; Easton DF; Eeles RA BJU Int; 2011 Jan; 107(1):28-39. PubMed ID: 20840664 [TBL] [Abstract][Full Text] [Related]
5. A review of targeted screening for prostate cancer: introducing the IMPACT study. Mitra AV; Bancroft EK; Eeles RA; BJU Int; 2007 Jun; 99(6):1350-5. PubMed ID: 17419707 [No Abstract] [Full Text] [Related]
6. Male BRCA1 and BRCA2 mutation carriers: a pilot study investigating medical characteristics of patients participating in a prostate cancer prevention clinic. Horsburgh S; Matthew A; Bristow R; Trachtenberg J Prostate; 2005 Oct; 65(2):124-9. PubMed ID: 15880530 [TBL] [Abstract][Full Text] [Related]
7. BRCA1 and BRCA2 mutations have no major role in predisposition to prostate cancer in Finland. Ikonen T; Matikainen MP; Syrjäkoski K; Mononen N; Koivisto PA; Rökman A; Seppälä EH; Kallioniemi OP; Tammela TL; Schleutker J J Med Genet; 2003 Aug; 40(8):e98. PubMed ID: 12920090 [No Abstract] [Full Text] [Related]
8. Ambiguity in a masculine world: Being a BRCA1/2 mutation carrier and a man with prostate cancer. Moynihan C; Bancroft EK; Mitra A; Ardern-Jones A; Castro E; Page EC; Eeles RA Psychooncology; 2017 Nov; 26(11):1987-1993. PubMed ID: 28812325 [TBL] [Abstract][Full Text] [Related]
9. [Update on genetic predisposition to prostate cancer]. Cussenot O; Cancel-Tassin G Bull Cancer; 2015 Jan; 102(1):53-6. PubMed ID: 25609482 [TBL] [Abstract][Full Text] [Related]
10. Mutations in BRCA1 and BRCA2 and predisposition to prostate cancer. Tischkowitz M; Eeles R; Lancet; 2003 Jul; 362(9377):80; author reply 80. PubMed ID: 12853213 [No Abstract] [Full Text] [Related]
11. Rapid progression of prostate cancer in men with a BRCA2 mutation. Narod SA; Neuhausen S; Vichodez G; Armel S; Lynch HT; Ghadirian P; Cummings S; Olopade O; Stoppa-Lyonnet D; Couch F; Wagner T; Warner E; Foulkes WD; Saal H; Weitzel J; Tulman A; Poll A; Nam R; Sun P; ; Danquah J; Domchek S; Tung N; Ainsworth P; Horsman D; Kim-Sing C; Maugard C; Eisen A; Daly M; McKinnon W; Wood M; Isaacs C; Gilchrist D; Karlan B; Nedelcu R; Meschino W; Garber J; Pasini B; Manoukian S; Bellati C Br J Cancer; 2008 Jul; 99(2):371-4. PubMed ID: 18577985 [TBL] [Abstract][Full Text] [Related]
12. The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer. Maia S; Cardoso M; Paulo P; Pinheiro M; Pinto P; Santos C; Pinto C; Peixoto A; Henrique R; Teixeira MR Fam Cancer; 2016 Jan; 15(1):111-21. PubMed ID: 26289772 [TBL] [Abstract][Full Text] [Related]
13. Germline BRCA mutations denote a clinicopathologic subset of prostate cancer. Gallagher DJ; Gaudet MM; Pal P; Kirchhoff T; Balistreri L; Vora K; Bhatia J; Stadler Z; Fine SW; Reuter V; Zelefsky M; Morris MJ; Scher HI; Klein RJ; Norton L; Eastham JA; Scardino PT; Robson ME; Offit K Clin Cancer Res; 2010 Apr; 16(7):2115-21. PubMed ID: 20215531 [TBL] [Abstract][Full Text] [Related]
14. A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology. Giusti RM; Rutter JL; Duray PH; Freedman LS; Konichezky M; Fisher-Fischbein J; Greene MH; Maslansky B; Fischbein A; Gruber SB; Rennert G; Ronchetti RD; Hewitt SM; Struewing JP; Iscovich J J Med Genet; 2003 Oct; 40(10):787-92. PubMed ID: 14569130 [No Abstract] [Full Text] [Related]
15. Increased risk of male cancer and identification of a potential prostate cancer cluster region in BRCA2. Roed Nielsen H; Petersen J; Therkildsen C; Skytte AB; Nilbert M Acta Oncol; 2016; 55(1):38-44. PubMed ID: 26360800 [TBL] [Abstract][Full Text] [Related]
16. Prostate Cancer Screening in a New Era of Genetics. Cheng HH; Pritchard CC; Montgomery B; Lin DW; Nelson PS Clin Genitourin Cancer; 2017 Dec; 15(6):625-628. PubMed ID: 28697982 [TBL] [Abstract][Full Text] [Related]
17. [The Campaign Program for Prostate Integrated Research]. Cussenot O Bull Cancer; 2010 Dec; 97(12):1497-8. PubMed ID: 21284142 [No Abstract] [Full Text] [Related]
18. Prostate-cancer screening targets men with BRCA mutations. Bonn D Lancet Oncol; 2002 Dec; 3(12):714. PubMed ID: 12473505 [No Abstract] [Full Text] [Related]
19. Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer. Hamel N; Kotar K; Foulkes WD BMC Med Genet; 2003 Aug; 4():7. PubMed ID: 12911837 [TBL] [Abstract][Full Text] [Related]
20. A cohort analysis of men with a family history of BRCA1/2 and Lynch mutations for prostate cancer. Kerr L; Rewhorn MJ; Longmuir M; Fraser S; Walsh S; Andrew N; Leung HY BMC Cancer; 2016 Jul; 16():529. PubMed ID: 27456091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]